Maxcyte, Inc.
Research company · Rockville, Maryland, United States · Nasdaq: MXCT
Maxcyte, Inc. is a research company headquartered in Rockville, Maryland, United States. Its shares trade on Nasdaq under the ticker MXCT. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1 million in total, most recently in 2008. It has reported private securities offerings to the US SEC, most recently $760,308 sold in a notice filed in 2016.
Maxcyte at a glance
What does Maxcyte do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1 million in total (2003 to 2008).
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $760,308 sold (2016).
Frequently asked questions about Maxcyte
Where is Maxcyte headquartered?
Maxcyte, Inc. is headquartered in Rockville, Maryland, United States.
What does Maxcyte do?
Maxcyte, Inc. is a research company. Its SEC industry classification is Services-Commercial Physical & Biological Research.
Is Maxcyte a public company?
Yes. Maxcyte, Inc. trades on Nasdaq under the ticker MXCT.
Similar companies
- Icagen, Inc.Durham, North Carolina, United States
- Absci CorpVancouver, Washington, United States
- SomaLogic, Inc.Boulder, Colorado, United States
- bioAffinity Technologies, Inc.San Antonio, Texas, United States
- iSpecimen Inc.Woburn, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.